Mizolastine
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
By mouth (tablets) |
ATC code | R06AX25 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 108612-45-9 ![]() |
PubChem (CID) | 65906 |
ChemSpider | 59315 ![]() |
UNII | 244O1F90NA ![]() |
KEGG | D01117 ![]() |
ChEMBL | CHEMBL94454 ![]() |
Chemical and physical data | |
Formula | C24H25FN6O |
Molar mass | 432.493 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Mizolastine (Mizollen) is a once-daily, non-sedating antihistamine. It blocks H1 receptors and is commonly fast-acting. It does not prevent the actual release of histamine from mast cells, just prevents it binding to receptors. Side effects can include dry mouth and throat.[1]
References[edit]
- ^ "MIZOLASTINE: British National Formulary". Retrieved 2010-02-01.
![]() |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |